Deleted Tweets From Scott Gottlieb, R-D.C.

#FDA announces a voluntary recall of several medicines containing valsartan following the detection of an impurity: https://t.co/mpKJp300Ln. https://t.co/7srndD0jjh

Grilling this weekend? Keep foods refrigerated, cook meats thoroughly, and remember to wash your hands and utensils. https://t.co/Pxs7W430Y4 https://t.co/RVEb1aT2fr

Manufacturing & quality issues are some of the proximate causes of drug shortages. Availability of raw materials; unexpected increases in demand, i.e. due to illness outbreaks or changes in clinical practice; or unavailability of other drugs in a class also can lead to a shortage https://t.co/wPqegvGsIq

We’ve seen # of new drug shortages steadily decline due to work by FDA, industry and others. In 2017, we worked w/ manufacturers to prevent 145 shortages. There were still 35 new shortages last year, but this compared to peak of 251 new shortages in ‘11 https://t.co/qnlwfXZeAp https://t.co/36kPdRlg2V

RT @FDAOncology: Dramatically increased survival rates for hematological malignancies & resulting changes in treatment should spur c… https://t.co/haDesrgBX8

The topic of this week’s #FDA #SUNDAYTWEETORIAL is #drugshortages. FDA does everything possible within our authority to help address shortages. While we’ve made progress to mitigate shortages; we must do even more to understand and address the root causes of persistent shortages

In 2012, in response the increase in drug shortages, Congress acted and gave #FDA new authority to help us prevent, mitigate and address shortages #FDASIA https://t.co/a1RXQzUlyt

Business decisions along the drug supply chain also can lead to shortages, e.g. decisions based on profitability, manufacturing costs, distribution quotas, patent life and company mergers. Many drugs in short supply have been low-profit generic medications https://t.co/6g9ZKcjpnG

Sterile injectables, which are critical for a wide range of medical treatments, are particularly at risk of shortage. Of the 35 new shortages in 2017, 26 were for sterile injectables drugs

Oncology fellows, do a rotation with #FDAOncology! Applications invited for eight-week Oncology Center of Excellence Fellows Program https://t.co/QSkMWo6FCO

#FDA is advising consumers who might have tried to buy drugs on-line of fake "FDA Warning Letters" that are being sent to people by international scam artists. #FDA wouldn't send a warning letter directly to consumers in such circumstances. Please be aware https://t.co/keO6Cle6t7 https://t.co/X0b4q5vysA

RT @FDAJobs: You want to make a difference. FDA wants to hire you. We have many exciting, cutting edge opportunities across the… https://t.co/7TR3y7slJo

RT @NYTHealth: Smallpox once terrified the world. The vaccine that eradicated it is too dangerous for many to take. Now, in case t… https://t.co/yfamf9OWVd

RT @FDAOncology: Metastasis-free Survival—A New End Point in Prostate Cancer Trials. #FDAOncology perspective in @NEJM… https://t.co/YQUBjUzsSj

RT @tmprowell: Program directors, send your fellows!! https://t.co/z5mcGp1xuL QT @FDAOncology: Oncology fellows, do a rotation with #FDAOncology! Applications invited for 8-week Oncology Center of Excellence Fe… https://t.co/OgM3W9lTqh)

RT @FDAWomen: #Pregnant? Visit FDA for resources to help you make good choices about medicines, foods, and other products for you… https://t.co/rEp5s6s334

RT @SGottliebFDA: The topic of this week’s #FDA #SUNDAYTWEETORIAL is #drugshortages. FDA does everything possible within our authorit… https://t.co/34k4cb05SS

RT @SeemaCMS: We continue to hear from physicians that excessive regulatory requirements and unnecessary paperwork steals time fr… https://t.co/giH74SauqV

RT @DrugInfoAssn: @US_FDA’s @SGottliebFDA to deliver Keynote at #DIA’s Complex Drug-Device Generic Combination Products Meeting… https://t.co/cE62VCQaua

RT @FDAOncology: Registration open: FDA public workshop on patient-focused drug development guidances Oct. 15-16, 2018, at FDA campu… https://t.co/Q8AVDM80oq

#FDA announces a voluntary recall of several medicines containing valsartan following the detection of an impurity: https://t.co/mpKJp300Ln. https://t.co/7srndD0jjh

Grilling this weekend? Keep foods refrigerated, cook meats thoroughly, and remember to wash your hands and utensils. https://t.co/Pxs7W430Y4 https://t.co/RVEb1aT2fr

Manufacturing & quality issues are some of the proximate causes of drug shortages. Availability of raw materials; unexpected increases in demand, i.e. due to illness outbreaks or changes in clinical practice; or unavailability of other drugs in a class also can lead to a shortage https://t.co/wPqegvGsIq

We’ve seen # of new drug shortages steadily decline due to work by FDA, industry and others. In 2017, we worked w/ manufacturers to prevent 145 shortages. There were still 35 new shortages last year, but this compared to peak of 251 new shortages in ‘11 https://t.co/qnlwfXZeAp https://t.co/36kPdRlg2V

RT @FDAOncology: Dramatically increased survival rates for hematological malignancies & resulting changes in treatment should spur c… https://t.co/haDesrgBX8

The topic of this week’s #FDA #SUNDAYTWEETORIAL is #drugshortages. FDA does everything possible within our authority to help address shortages. While we’ve made progress to mitigate shortages; we must do even more to understand and address the root causes of persistent shortages

In 2012, in response the increase in drug shortages, Congress acted and gave #FDA new authority to help us prevent, mitigate and address shortages #FDASIA https://t.co/a1RXQzUlyt

Business decisions along the drug supply chain also can lead to shortages, e.g. decisions based on profitability, manufacturing costs, distribution quotas, patent life and company mergers. Many drugs in short supply have been low-profit generic medications https://t.co/6g9ZKcjpnG

Sterile injectables, which are critical for a wide range of medical treatments, are particularly at risk of shortage. Of the 35 new shortages in 2017, 26 were for sterile injectables drugs

Oncology fellows, do a rotation with #FDAOncology! Applications invited for eight-week Oncology Center of Excellence Fellows Program https://t.co/QSkMWo6FCO

#FDA is advising consumers who might have tried to buy drugs on-line of fake "FDA Warning Letters" that are being sent to people by international scam artists. #FDA wouldn't send a warning letter directly to consumers in such circumstances. Please be aware https://t.co/keO6Cle6t7 https://t.co/X0b4q5vysA

RT @FDAJobs: You want to make a difference. FDA wants to hire you. We have many exciting, cutting edge opportunities across the… https://t.co/7TR3y7slJo

RT @NYTHealth: Smallpox once terrified the world. The vaccine that eradicated it is too dangerous for many to take. Now, in case t… https://t.co/yfamf9OWVd

RT @FDAOncology: Metastasis-free Survival—A New End Point in Prostate Cancer Trials. #FDAOncology perspective in @NEJM… https://t.co/YQUBjUzsSj

RT @tmprowell: Program directors, send your fellows!! https://t.co/z5mcGp1xuL QT @FDAOncology: Oncology fellows, do a rotation with #FDAOncology! Applications invited for 8-week Oncology Center of Excellence Fe… https://t.co/OgM3W9lTqh)

RT @FDAWomen: #Pregnant? Visit FDA for resources to help you make good choices about medicines, foods, and other products for you… https://t.co/rEp5s6s334

RT @SGottliebFDA: The topic of this week’s #FDA #SUNDAYTWEETORIAL is #drugshortages. FDA does everything possible within our authorit… https://t.co/34k4cb05SS

RT @SeemaCMS: We continue to hear from physicians that excessive regulatory requirements and unnecessary paperwork steals time fr… https://t.co/giH74SauqV

RT @DrugInfoAssn: @US_FDA’s @SGottliebFDA to deliver Keynote at #DIA’s Complex Drug-Device Generic Combination Products Meeting… https://t.co/cE62VCQaua

RT @FDAOncology: Registration open: FDA public workshop on patient-focused drug development guidances Oct. 15-16, 2018, at FDA campu… https://t.co/Q8AVDM80oq